{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T17:48:52Z","timestamp":1782755332915,"version":"3.54.5"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T00:00:00Z","timestamp":1776297600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T00:00:00Z","timestamp":1776297600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Indian Pediatr"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s13312-026-00342-3","type":"journal-article","created":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T10:08:44Z","timestamp":1776334124000},"page":"468-473","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Liver Fibrosis Screening in Childhood Acute Lymphoblastic Leukemia Survivors by Transient Elastography: A Case-Control Study"],"prefix":"10.1007","volume":"63","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4754-8340","authenticated-orcid":false,"given":"Sanjeev","family":"Khera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajay Shankar","family":"Prasad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajan","family":"Kapoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,16]]},"reference":[{"key":"342_CR1","doi-asserted-by":"crossref","unstructured":"Mulder RL, Bresters D, Van den Hof M, et al. Hepatic late adverse effects after antineoplastic treatment for childhood cancer. Cochrane Database Syst Rev. 2019;4:CD008205.","DOI":"10.1002\/14651858.CD008205.pub3"},{"key":"342_CR2","unstructured":"COG_LTFU_Guidelines_v5.pdf. Accessed on April 4, 2026. Available from: http:\/\/www.survivorshipguidelines.org\/pdf\/2018\/COG_LTFU_Guidelines_v5.pdf"},{"key":"342_CR3","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s12519-018-0197-8","volume":"14","author":"L Ruzman","year":"2018","unstructured":"Ruzman L, Mikolasevic I, Baraba Dekanic K, et al. Advances in diagnosis of chronic liver diseases in pediatric patients. World J Pediatr. 2018;14:541\u20137.","journal-title":"World J Pediatr"},{"key":"342_CR4","first-page":"940","volume":"10","author":"S Oeda","year":"2020","unstructured":"Oeda S, Tanaka K, Oshima A, et al. Diagnostic accuracy of FibroScan and factors affecting measurements. Diagn Basel Switz. 2020;10:940.","journal-title":"Diagn Basel Switz"},{"key":"342_CR5","doi-asserted-by":"publisher","first-page":"744","DOI":"10.4254\/wjh.v14.i4.744","volume":"14","author":"L Al Danaf","year":"2022","unstructured":"Al Danaf L, Hussein Kamareddine M, Fayad E, et al. Correlation between FibroScan and laboratory tests in non-alcoholic fatty liver disease\/non-alcoholic steatohepatitis patients for assessing liver fibrosis. World J Hepatol. 2022;14:744\u201353.","journal-title":"World J Hepatol"},{"key":"342_CR6","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.jhep.2016.04.023","volume":"65","author":"J Boursier","year":"2016","unstructured":"Boursier J, Vergniol J, Guillet A, et al. Diagnostic accuracy and prognostic significance of blood fibrosis tests and liver stiffness measurement by FibroScan in non-alcoholic fatty liver disease. J Hepatol. 2016;65:570\u20138.","journal-title":"J Hepatol"},{"key":"342_CR7","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1016\/j.jhep.2021.04.044","volume":"75","author":"EA Selvaraj","year":"2021","unstructured":"Selvaraj EA, M\u00f3zes FE, Jayaswal ANA, et al. Diagnostic accuracy of elastography and magnetic resonance imaging in patients with NAFLD: A systematic review and meta-analysis. J Hepatol. 2021;75:770\u201385.","journal-title":"J Hepatol"},{"key":"342_CR8","doi-asserted-by":"publisher","first-page":"3444","DOI":"10.1007\/s00261-020-02656-7","volume":"45","author":"IS Idilman","year":"2020","unstructured":"Idilman IS, Li J, Yin M, Venkatesh SK. MR elastography of liver: current status and future perspectives. Abdominal Radiology. 2020;45:3444\u201362.","journal-title":"Abdominal Radiology"},{"key":"342_CR9","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1111\/liv.14908","volume":"41","author":"LG Draijer","year":"2021","unstructured":"Draijer LG, van Oosterhout JPM, Vali Y, et al. Diagnostic accuracy of fibrosis tests in children with non-alcoholic fatty liver disease: a systematic review. Liver Int. 2021;41:2087\u2013100.","journal-title":"Liver Int"},{"key":"342_CR10","doi-asserted-by":"publisher","unstructured":"Khera S, Muhammed MKS, Kumar R, et al. Outcomes of childhood acute lymphoblastic leukemia treated with modified BFM-2009 protocol using measurable residual disease-based risk-stratification: a single-center study. Indian Pediatr. 2026 Feb 12. Online ahead of print. Available from: https:\/\/link.springer.com\/article\/https:\/\/doi.org\/10.1007\/s13312-026-00277-9. Accessed 11 Apr 2026.","DOI":"10.1007\/s13312-026-00277-9"},{"key":"342_CR11","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1186\/s12876-021-02038-3","volume":"21","author":"B Amernia","year":"2021","unstructured":"Amernia B, Moosavy SH, Banookh F, et al. FIB-4, APRI, and AST\/ALT ratio compared to FibroScan for the assessment of hepatic fibrosis in patients with non-alcoholic fatty liver disease in Bandar Abbas. Iran BMC Gastroenterol. 2021;21:453.","journal-title":"Iran BMC Gastroenterol"},{"key":"342_CR12","unstructured":"CDC. Obesity. 2024. Childhood Obesity Facts. Available from: https:\/\/www.cdc.gov\/obesity\/php\/data-research\/childhood-obesity-facts.html. Accessed 3 Aug 2024."},{"key":"342_CR13","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/S2352-4642(17)30043-3","volume":"1","author":"F Chiarelli","year":"2017","unstructured":"Chiarelli F, Mohn A. Early diagnosis of metabolic syndrome in children. Lancet Child Adolesc Health. 2017;1:86\u20138.","journal-title":"The Lancet Child & Adolescent Health"},{"key":"342_CR14","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1002\/hep.22376","volume":"48","author":"V Nobili","year":"2008","unstructured":"Nobili V, Vizzutti F, Arena U, et al. Accuracy and reproducibility of transient elastography for the diagnosis of fibrosis in pediatric nonalcoholic steatohepatitis. Hepatol Baltim Md. 2008;48:442\u20138.","journal-title":"Hepatol Baltim Md"},{"key":"342_CR15","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1016\/j.jhep.2016.12.022","volume":"66","author":"T Karlas","year":"2017","unstructured":"Karlas T, Petroff D, Sasso M, et al. Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis. J Hepatol. 2017;66:1022\u201330.","journal-title":"J Hepatol"},{"key":"342_CR16","doi-asserted-by":"publisher","first-page":"2602","DOI":"10.1111\/liv.14658","volume":"40","author":"DK Li","year":"2020","unstructured":"Li DK, Khan MR, Wang Z, et al. Normal liver stiffness and influencing factors in healthy children: an individual participant data meta\u2010analysis. Liver Int. 2020;40:2602\u201311.","journal-title":"Liver Int"},{"key":"342_CR17","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/s00431-011-1558-7","volume":"171","author":"G Engelmann","year":"2012","unstructured":"Engelmann G, Gebhardt C, Wenning D, et al. Feasibility study and control values of transient elastography in healthy children. Eur J Pediatr. 2012;171:353\u201360.","journal-title":"Eur J Pediatr"},{"key":"342_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2022.101547","volume":"51","author":"Y Cao","year":"2022","unstructured":"Cao Y, Xiang L, Qi F, et al. Accuracy of controlled attenuation parameter (CAP) and liver stiffness measurement (LSM) for assessing steatosis and fibrosis in non-alcoholic fatty liver disease: a systematic review and meta-analysis. eClinicalMedicine. 2022;51:101547.","journal-title":"eClinicalMedicine"},{"key":"342_CR19","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/6662760","volume":"2021","author":"R Sirli","year":"2021","unstructured":"Sirli R, Sporea I. Controlled attenuation parameter for quantification of steatosis: which cut-offs to use? Can J Gastroenterol Hepatol. 2021;2021:6662760.","journal-title":"Can J Gastroenterol Hepatol"},{"key":"342_CR20","doi-asserted-by":"publisher","first-page":"60","DOI":"10.5937\/jomb0-24689","volume":"40","author":"LA Chi-Cervera","year":"2021","unstructured":"Chi-Cervera LA, Montalvo GI, Icaza-Ch\u00e1vez ME, et al. Clinical relevance of lipid panel and aminotransferases in the context of hepatic steatosis and fibrosis as measured by transient elastography (FibroScan\u00ae). J Med Biochem. 2021;40:60\u20136.","journal-title":"J Med Biochem"},{"key":"342_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/1756-0500-7-207","volume":"7","author":"M Flechtner-Mors","year":"2014","unstructured":"Flechtner-Mors M, George SN, Oeztuerk S, et al. Association of adiponectin with hepatic steatosis: a study of 1,349 subjects in a random population sample. BMC Res Notes. 2014;7:207.","journal-title":"BMC Res Notes"},{"key":"342_CR22","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.ejca.2012.07.009","volume":"49","author":"RL Mulder","year":"2013","unstructured":"Mulder RL, Kremer LCM, Koot BGP, et al. Surveillance of hepatic late adverse effects in a large cohort of long-term survivors of childhood cancer: prevalence and risk factors. Eur J Cancer. 2013;49:185\u201393.","journal-title":"Eur J Cancer"},{"key":"342_CR23","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.2147\/IJGM.S309311","volume":"14","author":"VD Thong","year":"2021","unstructured":"Thong VD, Quynh BTH. Correlation of serum transaminase levels with liver fibrosis assessed by transient elastography in Vietnamese patients with nonalcoholic fatty liver disease. Int J Gen Med. 2021;14:1349\u201355.","journal-title":"Int J Gen Med"},{"key":"342_CR24","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1002\/1097-0142(196003\/04)13:2<288::AID-CNCR2820130213>3.0.CO;2-L","volume":"13","author":"RV Hutter","year":"1960","unstructured":"Hutter RV, Shipkey FH, Tan CT, et al. Hepatic fibrosis in children with acute leukemia. A complication of therapy. Cancer. 1960;13:288\u2013307.","journal-title":"Cancer"},{"key":"342_CR25","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1002\/cld.1008","volume":"17","author":"C Phen","year":"2021","unstructured":"Phen C, Ramirez CM. Hepatic steatosis in the pediatric population: an overview of pathophysiology, genetics, and diagnostic workup. Clin Liver Dis. 2021;17:191\u20135.","journal-title":"Clin Liver Dis"}],"container-title":["Indian Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13312-026-00342-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13312-026-00342-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13312-026-00342-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T17:37:38Z","timestamp":1782754658000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13312-026-00342-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,16]]},"references-count":25,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["342"],"URL":"https:\/\/doi.org\/10.1007\/s13312-026-00342-3","relation":{},"ISSN":["0019-6061","0974-7559"],"issn-type":[{"value":"0019-6061","type":"print"},{"value":"0974-7559","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,16]]},"assertion":[{"value":"4 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"None.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Institutional Ethics Committee Army Hospital R&R, Delhi; Ref No. IEC 59\/2024 dated July 16, 2024.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}}]}}